Ramakrishnan jayapradha (29 resultados)
- Tapa blanda
Librería: PBShop.store UK, Fairford, GLOS, Reino UnidoPBShop.store UK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 78,09
Envío por EUR 4,82Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.
- Tapa blanda
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de AmericaGreatBookPrices
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 83,04
Envío por EUR 2,28Se envía dentro de Estados Unidos de AmericaCantidad disponible: 3 disponibles
Condición: New.
- Tapa blanda
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de AmericaGreatBookPrices
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 84,10
Envío por EUR 2,28Se envía dentro de Estados Unidos de AmericaCantidad disponible: 5 disponibles
Condición: New.
- Tapa blanda
Librería: Rarewaves.com USA, London, LONDO, Reino UnidoRarewaves.com USA
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 86,46
Gastos de envío gratisSe envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Paperback. Condición: New. Antibiotics have vastly changed the way we fight diseases. History is replete with examples of infectious diseases that have killed millions of people worldwide in the past and continues to do so in the present. However, there is one major difference. In the past there were novel classes of antibiotics… that were being discovered at regular intervals, and in the present we are running out of options. Moreover, whatever antibiotics we have, microbes have developed resistance, which could primarily be attributed to the injudicious usage of antibiotics, not only for humans but also for veterinary purposes. A previous report from World Health Organization (WHO, 2017) suggests that antimicrobial resistance is a serious hazard and antibiotics under clinical development may not be sufficient (or efficient enough) to treat these emerging resistant pathogens. That report had identified 51 antibiotics and 11 biologicals. Of those, only 12 were found to be active against WHO classified critical priority pathogens and only two of them were found to be active against more than one specific pathogen. Starting with the sulphonamides in the 1930s to lipopeptides in the early 2000s, research and development on novel antibiotics is usually a slow and painful process and currently it will suffice to say that it is on the decline. As per the Infectious Diseases Society of America (IDSA), we are facing what is known as an antibiotic paradox that is pushing against the development of novel antibiotics. Interestingly, though there are studies that keep reporting on antibiotics, most of these are on combinatorial use of antibiotics. What could be their effectiveness and more importantly what could be their biotoxicity in the long run, remains unknown. Microbial antibiotic resistance is not a new phenomenon and there are numerous studies that have demonstrated the various mechanisms underlying it. An interesting study by Indian Council of Medical Research (ICMR), has shown that commensals in the gastrointestinal tract of humans might be responsible for the increasing ineffectiveness of antibiotics, at least in Indians. This makes it clear that microbes will keep on producing resistance to antibiotics at a faster rate compared to our ability to develop them. Under these circumstances, natural compounds, primarily plant-based, have become valuable tools and could be our answer to not only effective antimicrobial principles, but also to antimicrobial resistance. These compounds are abundant in nature and there is already a very rich literature on their usage and efficacy based on the various traditional systems of medicine. These natural compounds have been shown to be effective against both Gram positive and Gram-negative pathogens and interestingly microbes have a limited chance (as far as studies show) of developing resistance towards them. This is primarily attributed to the fact that most of these compounds are used as polyherbal formulations. Another advantage in study.
- Tapa blanda
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 86,47
Gastos de envío gratisSe envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponibles
Paperback. Condición: new. Paperback. Antibiotics have vastly changed the way we fight diseases. History is replete with examples of infectious diseases that have killed millions of people worldwide in the past and continues to do so in the present. However, there is one major difference. In the past there were novel classes of…antibiotics that were being discovered at regular intervals, and in the present we are running out of options. Moreover, whatever antibiotics we have, microbes have developed resistance, which could primarily be attributed to the injudicious usage of antibiotics, not only for humans but also for veterinary purposes. A previous report from World Health Organization (WHO, 2017) suggests that antimicrobial resistance is a serious hazard and antibiotics under clinical development may not be sufficient (or efficient enough) to treat these emerging resistant pathogens. That report had identified 51 antibiotics and 11 biologicals. Of those, only 12 were found to be active against WHO classified critical priority pathogens and only two of them were found to be active against more than one specific pathogen. Starting with the sulphonamides in the 1930s to lipopeptides in the early 2000s, research and development on novel antibiotics is usually a slow and painful process and currently it will suffice to say that it is on the decline. As per the Infectious Diseases Society of America (IDSA), we are facing what is known as an antibiotic paradox that is pushing against the development of novel antibiotics. Interestingly, though there are studies that keep reporting on antibiotics, most of these are on combinatorial use of antibiotics. What could be their effectiveness and more importantly what could be their biotoxicity in the long run, remains unknown. Microbial antibiotic resistance is not a new phenomenon and there are numerous studies that have demonstrated the various mechanisms underlying it. An interesting study by Indian Council of Medical Research (ICMR), has shown that commensals in the gastrointestinal tract of humans might be responsible for the increasing ineffectiveness of antibiotics, at least in Indians. This makes it clear that microbes will keep on producing resistance to antibiotics at a faster rate compared to our ability to develop them. Under these circumstances, natural compounds, primarily plant-based, have become valuable tools and could be our answer to not only effective antimicrobial principles, but also to antimicrobial resistance. These compounds are abundant in nature and there is already a very rich literature on their usage and efficacy based on the various traditional systems of medicine. These natural compounds have been shown to be effective against both Gram positive and Gram-negative pathogens and interestingly microbes have a limited chance (as far as studies show) of developing resistance towards them. This is primarily attributed to the fact that most of these compounds are used as polyherbal formulations. Another advantage in studying these natural compounds is that there is a better probability of hitting upon that jackpot molecule or molecules for antimicrobial applications. Being relatively safe and inexpensive makes them very attractive areas for clinical research. This book, in line with others in the field, is a small attempt to highlight the developments related to the antimicrobial compounds from natural sources and their mechanisms of action, particularly against ESKAPE pathogens. This book, we believe, will serve as a small but important piece of source material for students and researchers interested in this particular area of research. The chapters are divided to showcase the relevance and importance of natural compounds as novel antimicrobials, inhibitors of antimicrobial resistance and immunomodulators and we hope that the topics will kindle the interest of young researchers in these lines. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
- Tapa blanda
Librería: PBShop.store UK, Fairford, GLOS, Reino UnidoPBShop.store UK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 85,08
Envío por EUR 5,82Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 3 disponibles
PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.
- Tapa blanda
Librería: GreatBookPricesUK, Woodford Green, Reino UnidoGreatBookPricesUK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 78,08
Envío por EUR 17,38Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 3 disponibles
Condición: New.
- Tapa blanda
Librería: GreatBookPricesUK, Woodford Green, Reino UnidoGreatBookPricesUK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 78,84
Envío por EUR 17,38Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 5 disponibles
Condición: New.
- Tapa blanda
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandaKennys Bookshop and Art Galleries Ltd.
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 84,48
Envío por EUR 10,50Se envía de Irlanda a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Condición: New.
- Tapa blanda
Librería: THE SAINT BOOKSTORE, Southport, , Reino UnidoTHE SAINT BOOKSTORE
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 84,71
Envío por EUR 15,93Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Paperback / softback. Condición: New. New copy - Usually dispatched within 4 working days.
- Tapa blanda
Librería: THE SAINT BOOKSTORE, Southport, , Reino UnidoTHE SAINT BOOKSTORE
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 84,71
Envío por EUR 15,93Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 3 disponibles
Paperback / softback. Condición: New. New copy - Usually dispatched within 4 working days.
- Tapa blanda
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de AmericaKennys Bookstore
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 105,58
Envío por EUR 9,07Se envía dentro de Estados Unidos de AmericaCantidad disponible: 2 disponibles
Condición: New.
- Tapa blanda
Librería: moluna, Greven, , Alemaniamoluna
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 86,13
Envío por EUR 48,99Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 3 disponibles
Condición: New.
- Tapa blanda
Librería: Gazelle Books, Lancaster, LANCA, Reino UnidoGazelle Books
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 76,06
Envío por EUR 63,72Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Paperback. Condición: New. New Book, Direct from Publisher.
- Tapa blanda
Librería: Gazelle Books, Lancaster, LANCA, Reino UnidoGazelle Books
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 76,06
Envío por EUR 63,72Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 3 disponibles
Paperback. Condición: New. New Book, Direct from Publisher.
- Tapa blanda
Librería: Rarewaves.com UK, London, Reino UnidoRarewaves.com UK
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 78,83
Envío por EUR 75,31Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Paperback. Condición: New. Antibiotics have vastly changed the way we fight diseases. History is replete with examples of infectious diseases that have killed millions of people worldwide in the past and continues to do so in the present. However, there is one major difference. In the past there were novel classes of antibiotics… that were being discovered at regular intervals, and in the present we are running out of options. Moreover, whatever antibiotics we have, microbes have developed resistance, which could primarily be attributed to the injudicious usage of antibiotics, not only for humans but also for veterinary purposes. A previous report from World Health Organization (WHO, 2017) suggests that antimicrobial resistance is a serious hazard and antibiotics under clinical development may not be sufficient (or efficient enough) to treat these emerging resistant pathogens. That report had identified 51 antibiotics and 11 biologicals. Of those, only 12 were found to be active against WHO classified critical priority pathogens and only two of them were found to be active against more than one specific pathogen. Starting with the sulphonamides in the 1930s to lipopeptides in the early 2000s, research and development on novel antibiotics is usually a slow and painful process and currently it will suffice to say that it is on the decline. As per the Infectious Diseases Society of America (IDSA), we are facing what is known as an antibiotic paradox that is pushing against the development of novel antibiotics. Interestingly, though there are studies that keep reporting on antibiotics, most of these are on combinatorial use of antibiotics. What could be their effectiveness and more importantly what could be their biotoxicity in the long run, remains unknown. Microbial antibiotic resistance is not a new phenomenon and there are numerous studies that have demonstrated the various mechanisms underlying it. An interesting study by Indian Council of Medical Research (ICMR), has shown that commensals in the gastrointestinal tract of humans might be responsible for the increasing ineffectiveness of antibiotics, at least in Indians. This makes it clear that microbes will keep on producing resistance to antibiotics at a faster rate compared to our ability to develop them. Under these circumstances, natural compounds, primarily plant-based, have become valuable tools and could be our answer to not only effective antimicrobial principles, but also to antimicrobial resistance. These compounds are abundant in nature and there is already a very rich literature on their usage and efficacy based on the various traditional systems of medicine. These natural compounds have been shown to be effective against both Gram positive and Gram-negative pathogens and interestingly microbes have a limited chance (as far as studies show) of developing resistance towards them. This is primarily attributed to the fact that most of these compounds are used as polyherbal formulations. Another advantage in study.
- Tapa blanda
Librería: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 127,77
Envío por EUR 31,97Se envía de Australia a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Paperback. Condición: new. Paperback. Antibiotics have vastly changed the way we fight diseases. History is replete with examples of infectious diseases that have killed millions of people worldwide in the past and continues to do so in the present. However, there is one major difference. In the past there were novel classes of…antibiotics that were being discovered at regular intervals, and in the present we are running out of options. Moreover, whatever antibiotics we have, microbes have developed resistance, which could primarily be attributed to the injudicious usage of antibiotics, not only for humans but also for veterinary purposes. A previous report from World Health Organization (WHO, 2017) suggests that antimicrobial resistance is a serious hazard and antibiotics under clinical development may not be sufficient (or efficient enough) to treat these emerging resistant pathogens. That report had identified 51 antibiotics and 11 biologicals. Of those, only 12 were found to be active against WHO classified critical priority pathogens and only two of them were found to be active against more than one specific pathogen. Starting with the sulphonamides in the 1930s to lipopeptides in the early 2000s, research and development on novel antibiotics is usually a slow and painful process and currently it will suffice to say that it is on the decline. As per the Infectious Diseases Society of America (IDSA), we are facing what is known as an antibiotic paradox that is pushing against the development of novel antibiotics. Interestingly, though there are studies that keep reporting on antibiotics, most of these are on combinatorial use of antibiotics. What could be their effectiveness and more importantly what could be their biotoxicity in the long run, remains unknown. Microbial antibiotic resistance is not a new phenomenon and there are numerous studies that have demonstrated the various mechanisms underlying it. An interesting study by Indian Council of Medical Research (ICMR), has shown that commensals in the gastrointestinal tract of humans might be responsible for the increasing ineffectiveness of antibiotics, at least in Indians. This makes it clear that microbes will keep on producing resistance to antibiotics at a faster rate compared to our ability to develop them. Under these circumstances, natural compounds, primarily plant-based, have become valuable tools and could be our answer to not only effective antimicrobial principles, but also to antimicrobial resistance. These compounds are abundant in nature and there is already a very rich literature on their usage and efficacy based on the various traditional systems of medicine. These natural compounds have been shown to be effective against both Gram positive and Gram-negative pathogens and interestingly microbes have a limited chance (as far as studies show) of developing resistance towards them. This is primarily attributed to the fact that most of these compounds are used as polyherbal formulations. Another advantage in studying these natural compounds is that there is a better probability of hitting upon that jackpot molecule or molecules for antimicrobial applications. Being relatively safe and inexpensive makes them very attractive areas for clinical research. This book, in line with others in the field, is a small attempt to highlight the developments related to the antimicrobial compounds from natural sources and their mechanisms of action, particularly against ESKAPE pathogens. This book, we believe, will serve as a small but important piece of source material for students and researchers interested in this particular area of research. The chapters are divided to showcase the relevance and importance of natural compounds as novel antimicrobials, inhibitors of antimicrobial resistance and immunomodulators and we hope that the topics will kindle the interest of young researchers in Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
- Tapa blanda
Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 104,91
Envío por EUR 61,50Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Taschenbuch. Condición: Neu. Neuware - Opportunistic infections (OIs) are the growing concern as the microbe takes advantage when the immune system is weak. Even the microbes that reside in us for many years may cause serious disease when the immune system has weakened. Also, certain microbes get reactivated and cause opportunis…tic infections. Such common OIs include oral and pharyngeal candidiasis, Tuberculosis, Herpes Zoster, Bacterial pneumonia, Cryptoccal meningitis, Taxoplasmasis. Such secondary infections are common in immunocompromised and long term hospitalized severely ill patients. Currently, the incidence of secondary infections is increased world-wide in COVID-19 infected patients. The interface of biology, chemistry, computer science and mathematics has shown tremendous innovations in infectious diseases. In this book, such interdisciplinary approaches have been focused for the management of OIs. The edited book would be helpful for scientists, scholars, industrialist to obtain updated key information about interdisciplinary approaches to tackle opportunistic infections.
- Tapa blanda
Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 104,91
Envío por EUR 61,50Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Taschenbuch. Condición: Neu. Neuware.
- Tapa blanda
Librería: Mispah books, Redhill, SURRE, Reino UnidoMispah books
Contactar con el vendedorVendedor de 4 estrellasCondición: Usado - Como Nuevo
EUR 155,14
Envío por EUR 28,97Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Paperback. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
- Tapa blanda
Librería: GreatBookPricesUK, Woodford Green, Reino UnidoGreatBookPricesUK
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Como Nuevo
EUR 264,16
Envío por EUR 17,38Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 5 disponibles
Condición: As New. Unread book in perfect condition.
- Tapa blanda
Librería: GreatBookPricesUK, Woodford Green, Reino UnidoGreatBookPricesUK
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Como Nuevo
EUR 264,70
Envío por EUR 17,38Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 3 disponibles
Condición: As New. Unread book in perfect condition.
- Tapa blanda
Librería: Mispah books, Redhill, SURRE, Reino UnidoMispah books
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 256,57
Envío por EUR 28,97Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
paperback. Condición: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
- Tapa blanda
Librería: BOOKIT!, Genève, , SuizaBOOKIT!
Contactar con el vendedorVendedor de 3 estrellasCondición: Usado - Como Nuevo
EUR 233,45
Envío por EUR 53,50Se envía de Suiza a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Condición: Used: Like New. LIVRE A L?ETAT DE NEUF. EXPEDIE SOUS 3 JOURS OUVRES. NUMERO DE SUIVI COMMUNIQUE AVANT ENVOI, EMBALLAGE RENFORCE. EAN:9781536185034.
- Tapa blanda
Librería: BOOKIT!, Genève, , SuizaBOOKIT!
Contactar con el vendedorVendedor de 3 estrellasCondición: Usado - Como Nuevo
EUR 233,45
Envío por EUR 53,50Se envía de Suiza a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Condición: Used: Like New. LIVRE A L?ETAT DE NEUF. EXPEDIE SOUS 3 JOURS OUVRES. NUMERO DE SUIVI COMMUNIQUE AVANT ENVOI, EMBALLAGE RENFORCE. EAN:9781685079840.
- Tapa blanda
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de AmericaGreatBookPrices
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Como Nuevo
EUR 300,42
Envío por EUR 2,28Se envía dentro de Estados Unidos de AmericaCantidad disponible: 3 disponibles
Condición: As New. Unread book in perfect condition.
- Tapa blanda
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de AmericaGreatBookPrices
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Como Nuevo
EUR 300,45
Envío por EUR 2,28Se envía dentro de Estados Unidos de AmericaCantidad disponible: 5 disponibles
Condición: As New. Unread book in perfect condition.
- Tapa blanda
- Impresión bajo demanda
Librería: moluna, Greven, , Alemaniamoluna
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 52,71
Envío por EUR 48,99Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Kartoniert / Broschiert. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Ramakrishnan JayapradhaJayapradha Ramakrishnan, is working at SASTRA University as Assistant Professor for Microbiology in School of Chemical & Biotechnology for 5 years. She ha…s done her Master of Sciences and doctoral research in M.
- Tapa blanda
- Impresión bajo demanda
Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 68,82
Envío por EUR 61,34Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - A new species of Streptomycetes isolated from the rhizosphere soil of medicinal plants in Kolli hills of Tamil Nadu,India. The newly isolated strain Streptomyces designated as SCBT, is capable of inhibiting the growth of a wide range of…Gram negative bacteria. An almost complete 16S rRNA gene sequence of the isolate was generated and compared with sequences of representative Streptomyces. The 16S rRNA data not only supported the classification of the strain in the genus Streptomyces, but also showed that strain SCBT was most closely related to S. albogriseolus ATCC AJ494865 with a sequence similarity of 99%. Despite the high sequence similarity, strain SCBT was phenotypically different from S.albogrieseolus ATCC AJ494865 and sequence was submitted to NCBI and Accession number EU143270 was obtained. Phenetic and genetic results support the classification of strain SCBT as a new species. The purified compound from the new species exhibited a wide spectrum against various Gram negative and Gram positive organisms.
